{"id":5852,"date":"2019-07-22T15:26:51","date_gmt":"2019-07-22T15:26:51","guid":{"rendered":"https:\/\/todaysveterinarybusiness.com\/?p=5852"},"modified":"2022-03-07T21:30:05","modified_gmt":"2022-03-07T21:30:05","slug":"elanco-draws-closer-to-acquiring-aratana-therapeutics","status":"publish","type":"post","link":"https:\/\/navc.sitepreview.app\/todaysveterinarybusiness.com\/elanco-draws-closer-to-acquiring-aratana-therapeutics\/","title":{"rendered":"Elanco draws closer to acquiring Aratana Therapeutics"},"content":{"rendered":"

Stockholders at Aratana Therapeutics, which makes Galliprant, a canine osteoarthritis<\/a> NSAID, have approved a takeover bid from Elanco Animal Health.<\/p>\n

The companies did not report the current value of the sale, but it was estimated at $245 million<\/a> when first announced in April 2019.<\/p>\n

Besides Galliprant (grapiprant tablets), Elanco will get the canine appetite stimulant Entyce (capromorelin oral solution) and the 72-hour pain-relief drug Nocita (bupivacaine liposome injectable suspension).<\/p>\n

Aratana Therapeutics, based in Leawood, Kansas, held a shareholders meeting July 16, during which \u201c99% voted in favor,\u201d the company reported.<\/p>\n

The arrangement calls for Aratana stockholders to receive 0.1481 shares of Elanco common stock and one contingent value right (CVR) for each share of Aratana common stock.<\/p>\n

The deal will close after undisclosed \u201cconditions of the merger have been satisfied or waived,\u201d Aratana added.<\/p>\n

\u201cAratana\u2019s strong position in the specialty market \u2014 with their current portfolio and pipeline \u2014 complements Elanco\u2019s field presence and capitalizes on new opportunities for key existing Elanco pet therapy brands,\u201d said Jeff Simmons, Elanco\u2019s president and CEO.<\/p>\n

Elanco, whose 2018 sales rose to $3.1 billion, might not be done wheeling and dealing. Numerous media outlets reported that Elanco has engaged in merger talks with Bayer Animal Health.<\/p>\n","protected":false},"excerpt":{"rendered":"

Stockholders at Aratana Therapeutics, which makes Galliprant, a canine osteoarthritis NSAID, have approved a takeover bid from Elanco Animal Health.<\/p>\n","protected":false},"author":45,"featured_media":5853,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"iawp_total_views":0,"footnotes":""},"categories":[90],"tags":[],"class_list":["post-5852","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-online","column-news","clinical_topics-news"],"acf":{"hide_sidebar":false,"hide_sidebar_ad":false,"hide_all_ads":false},"yoast_head":"\nElanco draws closer to acquiring Aratana Therapeutics | Today's Veterinary Business<\/title>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Elanco draws closer to acquiring Aratana Therapeutics\" \/>\n<meta property=\"og:description\" content=\"Stockholders at Aratana Therapeutics, which makes Galliprant, a canine osteoarthritis NSAID, have approved a takeover bid from Elanco Animal Health.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/navc.sitepreview.app\/todaysveterinarybusiness.com\/elanco-draws-closer-to-acquiring-aratana-therapeutics\/\" \/>\n<meta property=\"og:site_name\" content=\"Today's Veterinary Business\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/todaysveterinarybusiness\" \/>\n<meta property=\"article:published_time\" content=\"2019-07-22T15:26:51+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-03-07T21:30:05+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/navc.sitepreview.app\/todaysveterinarybusiness.com\/wp-content\/uploads\/sites\/2\/2019\/07\/Business-Merger.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"680\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Louise S. Dunn\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@tvbpublication\" \/>\n<meta name=\"twitter:site\" content=\"@tvbpublication\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Louise S. Dunn\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/navc.sitepreview.app\\\/todaysveterinarybusiness.com\\\/elanco-draws-closer-to-acquiring-aratana-therapeutics\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/navc.sitepreview.app\\\/todaysveterinarybusiness.com\\\/elanco-draws-closer-to-acquiring-aratana-therapeutics\\\/\"},\"author\":{\"name\":\"Louise S. Dunn\",\"@id\":\"https:\\\/\\\/navc.sitepreview.app\\\/todaysveterinarybusiness.com\\\/#\\\/schema\\\/person\\\/06c2358bd95d11022006429d3cfecbeb\"},\"headline\":\"Elanco draws closer to acquiring Aratana Therapeutics\",\"datePublished\":\"2019-07-22T15:26:51+00:00\",\"dateModified\":\"2022-03-07T21:30:05+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/navc.sitepreview.app\\\/todaysveterinarybusiness.com\\\/elanco-draws-closer-to-acquiring-aratana-therapeutics\\\/\"},\"wordCount\":203,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/navc.sitepreview.app\\\/todaysveterinarybusiness.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/navc.sitepreview.app\\\/todaysveterinarybusiness.com\\\/elanco-draws-closer-to-acquiring-aratana-therapeutics\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/navc.sitepreview.app\\\/todaysveterinarybusiness.com\\\/wp-content\\\/uploads\\\/sites\\\/2\\\/2019\\\/07\\\/Business-Merger.jpg\",\"articleSection\":[\"Online\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/navc.sitepreview.app\\\/todaysveterinarybusiness.com\\\/elanco-draws-closer-to-acquiring-aratana-therapeutics\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/navc.sitepreview.app\\\/todaysveterinarybusiness.com\\\/elanco-draws-closer-to-acquiring-aratana-therapeutics\\\/\",\"url\":\"https:\\\/\\\/navc.sitepreview.app\\\/todaysveterinarybusiness.com\\\/elanco-draws-closer-to-acquiring-aratana-therapeutics\\\/\",\"name\":\"Elanco draws closer to acquiring Aratana Therapeutics | Today's Veterinary Business\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/navc.sitepreview.app\\\/todaysveterinarybusiness.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/navc.sitepreview.app\\\/todaysveterinarybusiness.com\\\/elanco-draws-closer-to-acquiring-aratana-therapeutics\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/navc.sitepreview.app\\\/todaysveterinarybusiness.com\\\/elanco-draws-closer-to-acquiring-aratana-therapeutics\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/navc.sitepreview.app\\\/todaysveterinarybusiness.com\\\/wp-content\\\/uploads\\\/sites\\\/2\\\/2019\\\/07\\\/Business-Merger.jpg\",\"datePublished\":\"2019-07-22T15:26:51+00:00\",\"dateModified\":\"2022-03-07T21:30:05+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/navc.sitepreview.app\\\/todaysveterinarybusiness.com\\\/elanco-draws-closer-to-acquiring-aratana-therapeutics\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/navc.sitepreview.app\\\/todaysveterinarybusiness.com\\\/elanco-draws-closer-to-acquiring-aratana-therapeutics\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/navc.sitepreview.app\\\/todaysveterinarybusiness.com\\\/elanco-draws-closer-to-acquiring-aratana-therapeutics\\\/#primaryimage\",\"url\":\"https:\\\/\\\/navc.sitepreview.app\\\/todaysveterinarybusiness.com\\\/wp-content\\\/uploads\\\/sites\\\/2\\\/2019\\\/07\\\/Business-Merger.jpg\",\"contentUrl\":\"https:\\\/\\\/navc.sitepreview.app\\\/todaysveterinarybusiness.com\\\/wp-content\\\/uploads\\\/sites\\\/2\\\/2019\\\/07\\\/Business-Merger.jpg\",\"width\":1280,\"height\":680,\"caption\":\"business acquisition\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/navc.sitepreview.app\\\/todaysveterinarybusiness.com\\\/elanco-draws-closer-to-acquiring-aratana-therapeutics\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/navc.sitepreview.app\\\/todaysveterinarybusiness.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Elanco draws closer to acquiring Aratana Therapeutics\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/navc.sitepreview.app\\\/todaysveterinarybusiness.com\\\/#website\",\"url\":\"https:\\\/\\\/navc.sitepreview.app\\\/todaysveterinarybusiness.com\\\/\",\"name\":\"Today's Veterinary Business\",\"description\":\"Veterinary Business Magazine\",\"publisher\":{\"@id\":\"https:\\\/\\\/navc.sitepreview.app\\\/todaysveterinarybusiness.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/navc.sitepreview.app\\\/todaysveterinarybusiness.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/navc.sitepreview.app\\\/todaysveterinarybusiness.com\\\/#organization\",\"name\":\"Today's Veterinary Business\",\"url\":\"https:\\\/\\\/navc.sitepreview.app\\\/todaysveterinarybusiness.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/navc.sitepreview.app\\\/todaysveterinarybusiness.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/todaysveterinarybusiness.com\\\/wp-content\\\/uploads\\\/sites\\\/2\\\/2022\\\/02\\\/tvb-logo.png\",\"contentUrl\":\"https:\\\/\\\/todaysveterinarybusiness.com\\\/wp-content\\\/uploads\\\/sites\\\/2\\\/2022\\\/02\\\/tvb-logo.png\",\"width\":258,\"height\":71,\"caption\":\"Today's Veterinary Business\"},\"image\":{\"@id\":\"https:\\\/\\\/navc.sitepreview.app\\\/todaysveterinarybusiness.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/todaysveterinarybusiness\",\"https:\\\/\\\/x.com\\\/tvbpublication\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/todaysveterinarybusiness\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/navc.sitepreview.app\\\/todaysveterinarybusiness.com\\\/#\\\/schema\\\/person\\\/06c2358bd95d11022006429d3cfecbeb\",\"name\":\"Louise S. Dunn\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/279afec084b15ccaa49dd347b051da6bd5240661c20b0dd5410687e84182ede5?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/279afec084b15ccaa49dd347b051da6bd5240661c20b0dd5410687e84182ede5?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/279afec084b15ccaa49dd347b051da6bd5240661c20b0dd5410687e84182ede5?s=96&d=mm&r=g\",\"caption\":\"Louise S. Dunn\"},\"sameAs\":[\"http:\\\/\\\/www.tvb.com\"]}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Elanco draws closer to acquiring Aratana Therapeutics | Today's Veterinary Business","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"en_US","og_type":"article","og_title":"Elanco draws closer to acquiring Aratana Therapeutics","og_description":"Stockholders at Aratana Therapeutics, which makes Galliprant, a canine osteoarthritis NSAID, have approved a takeover bid from Elanco Animal Health.","og_url":"https:\/\/navc.sitepreview.app\/todaysveterinarybusiness.com\/elanco-draws-closer-to-acquiring-aratana-therapeutics\/","og_site_name":"Today's Veterinary Business","article_publisher":"https:\/\/www.facebook.com\/todaysveterinarybusiness","article_published_time":"2019-07-22T15:26:51+00:00","article_modified_time":"2022-03-07T21:30:05+00:00","og_image":[{"width":1280,"height":680,"url":"https:\/\/navc.sitepreview.app\/todaysveterinarybusiness.com\/wp-content\/uploads\/sites\/2\/2019\/07\/Business-Merger.jpg","type":"image\/jpeg"}],"author":"Louise S. Dunn","twitter_card":"summary_large_image","twitter_creator":"@tvbpublication","twitter_site":"@tvbpublication","twitter_misc":{"Written by":"Louise S. Dunn","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/navc.sitepreview.app\/todaysveterinarybusiness.com\/elanco-draws-closer-to-acquiring-aratana-therapeutics\/#article","isPartOf":{"@id":"https:\/\/navc.sitepreview.app\/todaysveterinarybusiness.com\/elanco-draws-closer-to-acquiring-aratana-therapeutics\/"},"author":{"name":"Louise S. Dunn","@id":"https:\/\/navc.sitepreview.app\/todaysveterinarybusiness.com\/#\/schema\/person\/06c2358bd95d11022006429d3cfecbeb"},"headline":"Elanco draws closer to acquiring Aratana Therapeutics","datePublished":"2019-07-22T15:26:51+00:00","dateModified":"2022-03-07T21:30:05+00:00","mainEntityOfPage":{"@id":"https:\/\/navc.sitepreview.app\/todaysveterinarybusiness.com\/elanco-draws-closer-to-acquiring-aratana-therapeutics\/"},"wordCount":203,"commentCount":0,"publisher":{"@id":"https:\/\/navc.sitepreview.app\/todaysveterinarybusiness.com\/#organization"},"image":{"@id":"https:\/\/navc.sitepreview.app\/todaysveterinarybusiness.com\/elanco-draws-closer-to-acquiring-aratana-therapeutics\/#primaryimage"},"thumbnailUrl":"https:\/\/navc.sitepreview.app\/todaysveterinarybusiness.com\/wp-content\/uploads\/sites\/2\/2019\/07\/Business-Merger.jpg","articleSection":["Online"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/navc.sitepreview.app\/todaysveterinarybusiness.com\/elanco-draws-closer-to-acquiring-aratana-therapeutics\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/navc.sitepreview.app\/todaysveterinarybusiness.com\/elanco-draws-closer-to-acquiring-aratana-therapeutics\/","url":"https:\/\/navc.sitepreview.app\/todaysveterinarybusiness.com\/elanco-draws-closer-to-acquiring-aratana-therapeutics\/","name":"Elanco draws closer to acquiring Aratana Therapeutics | Today's Veterinary Business","isPartOf":{"@id":"https:\/\/navc.sitepreview.app\/todaysveterinarybusiness.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/navc.sitepreview.app\/todaysveterinarybusiness.com\/elanco-draws-closer-to-acquiring-aratana-therapeutics\/#primaryimage"},"image":{"@id":"https:\/\/navc.sitepreview.app\/todaysveterinarybusiness.com\/elanco-draws-closer-to-acquiring-aratana-therapeutics\/#primaryimage"},"thumbnailUrl":"https:\/\/navc.sitepreview.app\/todaysveterinarybusiness.com\/wp-content\/uploads\/sites\/2\/2019\/07\/Business-Merger.jpg","datePublished":"2019-07-22T15:26:51+00:00","dateModified":"2022-03-07T21:30:05+00:00","breadcrumb":{"@id":"https:\/\/navc.sitepreview.app\/todaysveterinarybusiness.com\/elanco-draws-closer-to-acquiring-aratana-therapeutics\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/navc.sitepreview.app\/todaysveterinarybusiness.com\/elanco-draws-closer-to-acquiring-aratana-therapeutics\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/navc.sitepreview.app\/todaysveterinarybusiness.com\/elanco-draws-closer-to-acquiring-aratana-therapeutics\/#primaryimage","url":"https:\/\/navc.sitepreview.app\/todaysveterinarybusiness.com\/wp-content\/uploads\/sites\/2\/2019\/07\/Business-Merger.jpg","contentUrl":"https:\/\/navc.sitepreview.app\/todaysveterinarybusiness.com\/wp-content\/uploads\/sites\/2\/2019\/07\/Business-Merger.jpg","width":1280,"height":680,"caption":"business acquisition"},{"@type":"BreadcrumbList","@id":"https:\/\/navc.sitepreview.app\/todaysveterinarybusiness.com\/elanco-draws-closer-to-acquiring-aratana-therapeutics\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/navc.sitepreview.app\/todaysveterinarybusiness.com\/"},{"@type":"ListItem","position":2,"name":"Elanco draws closer to acquiring Aratana Therapeutics"}]},{"@type":"WebSite","@id":"https:\/\/navc.sitepreview.app\/todaysveterinarybusiness.com\/#website","url":"https:\/\/navc.sitepreview.app\/todaysveterinarybusiness.com\/","name":"Today's Veterinary Business","description":"Veterinary Business Magazine","publisher":{"@id":"https:\/\/navc.sitepreview.app\/todaysveterinarybusiness.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/navc.sitepreview.app\/todaysveterinarybusiness.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/navc.sitepreview.app\/todaysveterinarybusiness.com\/#organization","name":"Today's Veterinary Business","url":"https:\/\/navc.sitepreview.app\/todaysveterinarybusiness.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/navc.sitepreview.app\/todaysveterinarybusiness.com\/#\/schema\/logo\/image\/","url":"https:\/\/todaysveterinarybusiness.com\/wp-content\/uploads\/sites\/2\/2022\/02\/tvb-logo.png","contentUrl":"https:\/\/todaysveterinarybusiness.com\/wp-content\/uploads\/sites\/2\/2022\/02\/tvb-logo.png","width":258,"height":71,"caption":"Today's Veterinary Business"},"image":{"@id":"https:\/\/navc.sitepreview.app\/todaysveterinarybusiness.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/todaysveterinarybusiness","https:\/\/x.com\/tvbpublication","https:\/\/www.linkedin.com\/company\/todaysveterinarybusiness"]},{"@type":"Person","@id":"https:\/\/navc.sitepreview.app\/todaysveterinarybusiness.com\/#\/schema\/person\/06c2358bd95d11022006429d3cfecbeb","name":"Louise S. Dunn","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/279afec084b15ccaa49dd347b051da6bd5240661c20b0dd5410687e84182ede5?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/279afec084b15ccaa49dd347b051da6bd5240661c20b0dd5410687e84182ede5?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/279afec084b15ccaa49dd347b051da6bd5240661c20b0dd5410687e84182ede5?s=96&d=mm&r=g","caption":"Louise S. Dunn"},"sameAs":["http:\/\/www.tvb.com"]}]}},"_links":{"self":[{"href":"https:\/\/navc.sitepreview.app\/todaysveterinarybusiness.com\/wp-json\/wp\/v2\/posts\/5852","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/navc.sitepreview.app\/todaysveterinarybusiness.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/navc.sitepreview.app\/todaysveterinarybusiness.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/navc.sitepreview.app\/todaysveterinarybusiness.com\/wp-json\/wp\/v2\/users\/45"}],"replies":[{"embeddable":true,"href":"https:\/\/navc.sitepreview.app\/todaysveterinarybusiness.com\/wp-json\/wp\/v2\/comments?post=5852"}],"version-history":[{"count":2,"href":"https:\/\/navc.sitepreview.app\/todaysveterinarybusiness.com\/wp-json\/wp\/v2\/posts\/5852\/revisions"}],"predecessor-version":[{"id":19116,"href":"https:\/\/navc.sitepreview.app\/todaysveterinarybusiness.com\/wp-json\/wp\/v2\/posts\/5852\/revisions\/19116"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/navc.sitepreview.app\/todaysveterinarybusiness.com\/wp-json\/wp\/v2\/media\/5853"}],"wp:attachment":[{"href":"https:\/\/navc.sitepreview.app\/todaysveterinarybusiness.com\/wp-json\/wp\/v2\/media?parent=5852"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/navc.sitepreview.app\/todaysveterinarybusiness.com\/wp-json\/wp\/v2\/categories?post=5852"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/navc.sitepreview.app\/todaysveterinarybusiness.com\/wp-json\/wp\/v2\/tags?post=5852"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}